SCHEMBL20799490

SCHEMBL20799490

CCOC(=O)c1cnc2cc3c(cc2c1C)OCO3

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 11/20 0.60
ALDH1A1 P00352 11/20 0.60
HTT P42858 6/20 0.60
NPSR1 Q6W5P4 5/20 0.60
HPGD P15428 7/20 0.57
SMN1; SMN2 Q16637 6/20 0.57
MAPT P10636 6/20 0.57
KDM4E B2RXH2 4/20 0.48
ATM Q13315 1/20 0.48
MAPK1 P28482 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
POLB P06746 1/20 0.45
CLK1 P49759 1/20 0.45
HSD17B10 Q99714 2/20 0.44
ALOX15 P16050 1/20 0.44
JAK2 O60674 1/20 0.43
JAK3 P52333 1/20 0.43
CASP1 P29466 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL242405 0.89 ALDH1A1 (0.50) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL5929729 0.88 ALDH1A1 (0.52) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL11792492 0.88 ALDH1A1 (0.49) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL20799493 0.87 ALDH1A1 (0.65) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL5929721 0.80 LMNA (0.53) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL2605617 0.79 DPP4 (0.49) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL25656349 0.79 KMT2A (0.48) LMNAALDH1A1NPSR1SMN1; SMN2MAPT
SCHEMBL11791126 0.77 ALDH1A1 (0.48) LMNAALDH1A1HTTNPSR1HPGD
SCHEMBL17384693 0.76 LMNA (0.52) LMNAALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL2605586 0.76 ALDH1A1 (0.44) LMNAALDH1A1HTTNPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227355-B2 Quinoline derivatives and preparation thereof ABL1, FLT3, MAP3K7 LMNA 2995/4885ALDH1A1 2096/4885HTT 3639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.